Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Moderate agonism at human S1P4 and S1P5 is observed but is reduced relative to S1P1
44(12):1881-1889
CP-91149 treatment decreases muscle GP activity by converting the phosphorylated AMP-independent α form into the dephosphorylated AMP-dependent b form and inhibiting GP α activity and AMP-mediated GP b activation
Drugs acting at the noiciceptin receptor may influence the effects of traditional analgesics such as NSAIDs
Resistomycin Catalog No.:M22650-C Moderate agonism at human S1P4Resistomycin is a natural antibiotic. Resistomycin is a natural antibiotic produced by several actinobacteriae, such as Streptomyces. In vitro: Resistomycin, a tetrahydroxyanthrone derivative, was isolated from the culture broth of Streptomyces sulphureus and a similar polyphenolic dianthraquinone, hypericin, was isolated from an extract of Hypericum perforatum L. as modulators for apoptosis. In human megakaryoblastic leukemia CMK 7 cells,
US$ 749.50
US$ 1999.50
US$ 4999.50
US$ 1499.50
US$ 3249.50
US$ 5499.50
US$ 8999.50
US$ 3999.50
US$ 79.00
US$ 119.00
US$ 59999.50
US$ 849.50
US$ 4999.50